Equity Awards and Instruments (Tables)

6 Months Ended

Jun. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

Total stock‑based compensation expense was as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2021		2020		2021		2020
Stock option expense	$	723	$	1,422	$	1,721	$	2,956
Restricted stock and restricted stock units (“RSUs”) expense	4,961		37		6,458		37
Stock grants expense	450		100		450		219
Bonus Plan expense (see Note 11)	5,471		—		11,595		—
ESPP expense (see Note 13)	428		—		877		—
Total pre-tax expense (1)	$	12,033	$	1,559	$	21,101	$	3,212

(1)As of June 30, 2021 and December 31, 2020, $6,169 and $6,835 remained in Accruals and other current liabilities in the consolidated balance sheets, respectively.

Total stock‑based compensation expense is included in the consolidated statements of operations as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2021		2020		2021		2020
Cost of subscriptions and licenses	$	410	$	19	$	499	$	47
Cost of services	207		79		450		175
Research and development	4,887		536		8,842		1,155
Selling and marketing	1,515		404		2,303		804
General and administrative	5,014		521		9,007		1,031
Total pre-tax expense	$	12,033	$	1,559	$	21,101	$	3,212

Schedule of Options

The following is a summary of stock option activity and related information under the Company’s applicable equity incentive plans:

				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
	Stock	Exercise Price		Contractual	Intrinsic
	Options	Per Share		Life (in years)	Value
Outstanding, December 31, 2020	12,842,226	$	4.87
Exercised	(4,517,393)	4.30
Forfeited	(120,500)	5.54
Outstanding, June 30, 2021	8,204,333	$	5.18	1.97	$	488,976
Exercisable, June 30, 2021	4,973,958	$	4.91	1.67	$	297,780

Schedule of Restricted Stock and Restricted Stock Unit Activity

The following is a summary of unvested restricted stock and RSU activity and related information under the Company’s applicable equity incentive plans:

						Time-		Performance-
						Based		Based
			Time-	Performance-		Weighted		Weighted
	Total		Based	Based		Average		Average
	Restricted		Restricted	Restricted		Grant Date		Grant Date
	Stock		Stock	Stock		Fair Value		Fair Value
	and RSUs		and RSUs	and RSUs		Per Share		Per Share
Unvested, December 31, 2020	1,423,715		1,263,193	160,522	(3)	$	16.38	$	16.62
Granted	602,616	(1)	502,808	99,808	(4)	49.85		49.93
Vested	(41,695)		(6,765)	(34,930)	(3)	24.15		17.53
Forfeited	(147,672)		(22,080)	(125,592)		17.17		16.36
Unvested, June 30, 2021	1,836,964	(2)	1,737,156	99,808		$	26.02	$	49.93

(1)For the six months ended June 30, 2021, the Company only granted RSUs. No shares of restricted stock were granted during the six months ended June 30, 2021.

(2)Includes 56,360 RSUs which are expected to be settled in cash.

(3)Relates to the 2020 annual performance period. Total stock‑based compensation expense associated with these awards was fully recognized as of December 31, 2020.

(4)Relates to the 2021 annual performance period.